Dental Surgical Robot Company Secures New Strategic Investment; Dentsply Sirona, Henry Schein, and Straumann Release Financial Reports; Two Major Consumer Dental Brands Consolidate; U.S. Dental Service Organization (DSO) Public Company Projects 2025 Same-Store Revenue Growth of 3.5%-5.0%...

Dental Surgical Robot Company Yangshan Medical Secures Strategic Investment, Pre-Series A Financing Totals Nearly 100 Million Yuan

Dental Surgical Robot company Yangshan Medical announced the completion of nearly 100 million yuan in Pre-Series A and Pre-Series A+ Financing. Aidite (Qinhuangdao) Technology Co., Ltd. acted as the lead investor in the Pre-Series A+ round, with Danlu Capital participating. Yangshan Medical's core product, the PlanT Dental Surgical Robot, received NMPA market approval on February 12, 2026, and has already secured several commercial orders. This investment aims to combine Aidite's channel resources with Yangshan Medical's technology to promote the implementation of a full-chain Computer-Aided Implant Surgery (CAIS) solution.

Dentsply Sirona Showcases Full Portfolio at South China International Stomatological Exhibition, New Products Debut Alongside Cercon's 25th Anniversary

*Dentsply Sirona Booth Schematic

From March 3 to 6, 2026, Dentsply Sirona participated in the 31st South China International Stomatological Exhibition at the China Import and Export Fair Complex, showcasing its full portfolio across Implant, Equipment, Consumables, and Laboratory product lines at Booth F12 in Hall 20.2. The exhibition focused on "Digital Implantology Solutions" and "Core Treatment Solutions," offering a complete clinical chain. The implant line highlighted the PrimeTaper® and OmniTaper® Implant Systems. The equipment area centered on the Prime CEREC Platinum Chairside System. The Consumables area displayed new products like X-Smart Pro and SDR® Plus. Marking Cercon's 25th anniversary, the laboratory area launched the new Portrait IPN resin teeth. A Cercon 25th Anniversary and new product launch event will be held on the afternoon of March 3, with registration open.

Dentsply Sirona 2025 Q4: Net Sales of $961 Million, Up 6.2% Year-over-Year

Dentsply Sirona released its financial results for the fourth quarter and full year of 2025. Fourth-quarter net sales were $961 million, a 6.2% increase year-over-year. Full-year net sales were $3.68 billion, down 3.0% year-over-year. Due to goodwill and intangible asset impairment charges of $650 million, the full-year net loss reached $598 million. The company announced a suspension of its dividend and initiated a restructuring plan expected to achieve annualized savings of $120 million. For 2026, net sales are projected to be in the range of $3.5 to $3.6 billion.

Henry Schein: Q4 2025 Revenue of $3.437 Billion, 7.7% Growth Marks Highest in Nearly 15 Quarters

Henry Schein, Inc. announced its financial results for the fourth quarter and full year of 2025. Q4 revenue was $3.437 billion, a year-over-year increase of 7.7%, representing the highest growth rate in nearly 15 quarters. Full-year revenue totaled $13.184 billion, up 4.0% year-over-year. Q4 global dental distribution equipment sales grew 12.2%, and specialty product sales (including Dental Implants and endodontic products) increased 14.6%. GAAP Net Profit Attributable to Shareholders of the Parent Company was $101 million, up 7.9% year-over-year; the full-year GAAP figure was $398 million, a 2.2% increase. The company expects 2026 Non-GAAP Diluted EPS to be in the range of $5.23 to $5.37, with projected sales growth of 3% to 5%.

Solventum: 2025 Q4 Dental Business Revenue of $343 Million, Up 8.6% Year-over-Year

Solventum released its fourth-quarter 2025 financial results. Overall net sales decreased 3.7% year-over-year, but its dental business achieved revenue of $343 million, an 8.6% increase. Organic growth, excluding currency effects, was 5.9%. Full-year dental business sales reached $1.349 billion, up 4.2% year-over-year. The dental segment's operating margin for Q4 was 24.4%, higher than the 23.3% from the same period last year. Looking ahead to 2026, the company expects full-year organic sales growth of 2.0% to 3.0% and free cash flow of approximately $200 million.

U.S. Dental DSO Public Company 2025 Annual Report: Revenue of $244.49 Million, Up 6.4% Year-over-Year

U.S. Dental Service Organization (DSO) public company Park Dental Partners, Inc. released its fourth-quarter and full-year 2025 results. Full-year revenue reached $244.49 million, a 6.4% increase year-over-year, with Same-store sales growth rebounding from -0.8% to +5.8%. The full-year net loss was $358,000, impacted by IPO-related share-based payment expenses. Total patient visits for the year were 719,295, with a Patient retention rate of 89.9%. The company expects 2026 revenue to increase approximately 4.7% year-over-year, with Same-store sales growth projected between 3.5% and 5.0%.

Zenyum and MakeO Announce Merger, Two Consumer Dental Brands to Integrate Covering 10 Major Markets

Singapore-based consumer dental company Zenyum and India's MakeO Toothsi announced plans for a strategic merger. The merger is expected to be completed by the end of February 2026, pending customary approvals. The combined entity will cover markets including India, Taiwan (China), Japan, Hong Kong (China), Singapore, Malaysia, Vietnam, Saudi Arabia, Qatar, and the UAE, with a network of approximately 1,100 partner dentists and an audit team of about 80 dental and Orthodontics professionals. This is an "equal merger," with Zenyum becoming a subsidiary under the MakeO holding structure. MakeO's Mumbai headquarters will serve as the headquarters for the combined entity, while Zenyum's Singapore office will continue as the regional headquarters for Southeast and North Asia operations.

Stratasys Launches Multi-Material 3D Printed Dental Models, Customizable and Replacing Gross Specimens

3D printing solutions provider Stratasys released a preset for Dental Anatomical Models for simulation training. Utilizing multi-material 3D printing technology, it provides dental schools, training centers, and medical device manufacturers with highly realistic, reproducible anatomical models, replacing gross specimens and animal specimens used in traditional teaching. The models support various surgical techniques including tooth extraction, implant placement, periodontal surgery, endodontic surgery, and sinus lifts. They can also be personalized based on patient Cone Beam Computed Tomography (CBCT) scan data to reflect specific pathological conditions. This release aims to enhance students' clinical readiness and help commercial training centers reduce training costs.

Dutch Dental Chain Atlas Accused of Systematic Billing Tampering, Involving 9 Clinics

Dutch commercial dental chain Atlas Dental Care has been accused of systematically tampering with patients' health insurance bills, involving 9 clinics. An investigation revealed that bill modifications were manually performed by head office staff weeks after treatment concluded. Operations included adding treatment items that did not actually occur, pre-billing for dentures, and scheduling annual X-ray checks without clinical necessity. Atlas denied the allegations regarding 21 bills, stating the adjustments were merely administrative corrections. The Royal Dutch Dental Association announced that Atlas would be expelled if found involved.

U.S. Dental Hiring Demand Contracts, Job Postings Down 11.6% Over Past Year

A report titled "U.S. Healthcare Labor Market Update" released by the Hiring Lab, a research institute under the global recruitment platform Indeed, shows that U.S. dental job postings declined by 11.6% over the past year. Despite the drop, dental job postings remain 36.3% higher than the pre-COVID-19 baseline of February 1, 2020. Regarding compensation, wage growth in the dental industry remained flat over the six months ending December 2025. Signs of demand contraction had emerged earlier; the report noted that as of January 17, 2025, the year-over-year decline in dental job postings was only 2.1%. Comparing the two reports, the year-over-year decline in dental job postings widened from 2.1% to 11.6%, a more than fivefold increase in the decline over approximately one year.

Topdent Executives Increase Holdings by 1.8161 Million Yuan, Five Individuals Plan Total Up to 12 Million Yuan

Five executives of Topdent Medical Co., Ltd. completed an increase in their holdings of the company's shares, totaling 1.8161 million yuan. The increase was executed by Chairman Wang Yi, Director Huang Yuhua, Board Secretary Zhang Hua, and management member Zhao Min. Following the increase, the shareholding ratios of Wang Yi, Huang Yuhua, and Zhang Hua each reached 0.002%, while Zhao Min's ratio increased from 0.0002% to 0.002%. A subsequent share increase plan will continue within the next six months, with an amount not less than 6 million yuan and not exceeding 12 million yuan. Specific increases will be implemented based on market conditions. This share increase complies with relevant regulations and will not lead to changes in the controlling shareholder or actual controller.

New Research: Nitrate May Alleviate Bone Loss, Providing New Target for Regenerative Materials Development

A research team led by Academician Wang Songling of the Chinese Academy of Sciences, in collaboration with Southern University of Science and Technology and Southern Medical University, published a study in the authoritative journal Bone Research. The study reveals for the first time that nitrate alleviates age-related bone loss in animal models by upregulating Sialin expression, regulating mitochondrial energy metabolism, and improving the osteogenic capacity of aged mesenchymal stem cells. The research found that when the Slc17a5 gene is deficient, the mitochondrial function of bone marrow mesenchymal stem cells is impaired, and their osteogenic differentiation ability declines; supplementing with nitrate can improve this condition. The study received funding from multiple projects including the National Natural Science Foundation of China and the Beijing Municipal Government.